Loading...
•
Jun 30
Nano-X Q2 2025 Earnings Report
Nano-X posted a wider net loss in Q2 2025 despite slight revenue growth, reflecting continued investments in commercialization and product deployment.
Key Takeaways
In Q2 2025, Nano-X reported $3.04 million in revenue, a modest increase driven by growth in its teleradiology segment. However, the company reported a net loss of $14.7 million and a gross loss margin of 37.2%, as it continues investing in commercialization efforts for its imaging systems and AI platforms. Cash reserves decreased to $58.3 million, and the company reaffirmed its focus on product deployment and expanding imaging services.
Revenue reached $3.04 million, with growth led by teleradiology services
GAAP gross loss margin was 37.2%, driven by operating costs and rollout expenses
Net loss widened to $14.7 million, up from $12.1 million YoY
Cash balance declined to $58.3 million as the company continued deploying imaging systems
Nano-X
Nano-X
Nano-X Revenue by Segment
Revenue by Segment
Teleradiology Revenue
CapyFin.comImaging Products Revenue
CapyFin.comAI Solutions Revenue
CapyFin.com Forward Guidance
Nano-X plans to continue deploying its ARC systems globally and scaling teleradiology services, while managing cost structure and driving adoption of its AI technologies.
Positive Outlook
- Ongoing global deployment of Nanox.ARC systems
- Growth in teleradiology revenue quarter over quarter
- Continued demand for AI imaging solutions
- Enhanced operational efficiency in R&D and G&A
- Maintains strong intellectual property portfolio
Challenges Ahead
- Widening net loss due to scaling efforts
- Gross margin remains negative under GAAP
- Cash reserves decreased to $58.3 million
- Imaging product revenue declined YoY
- Continued high costs for commercialization and deployment